Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - April 9, 2024 Category: Cancer & Oncology Authors: Valentina Guarneri Jos é Luís Passos Coelho Francois P Duhoux Daniel Egle Jos é Ángel García-Sáenz Fr édérique Penault-Llorca Katri Selander Hans Wildiers Khalil Zaman Petra Laeis Markus Lucerna Jean-Yves Pierga Source Type: research